PROF Profound Medical Corp.
Profound Medical Corp. (PROF) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.23 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -7.7% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Profound Medical Corp.
Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
Sector
Healthcare
Industry
Medical Instruments/Supply